marijuana stocks news

Peak Pharmaceuticals, Inc. Announces Name Change From Cannabis Therapy Corp.

Corporate Business Plan Remains Focused on Development, Sales and Marketing of Hemp-Based Supplements and Medicinal Products

BOULDER, CO–(Marketwired – Jan 13, 2015) –Peak Pharmaceuticals, Inc. (OTCQB: CTCO),formerly Cannabis Therapy Corp. (the “Company”), a growth stage company aiming to become a leader in the research, development and commercialization of safe, all-natural, hemp-based medicinal therapies and supplements (Nutraceuticals), wishes to advise that on December 23, 2014, Cannabis Therapy Corp., a Nevada corporation, entered into an Agreement and Plan of Merger pursuant to which the shareholders of the Company became shareholders of the surviving company named Peak Pharmaceuticals, Inc., a Nevada corporation.

The Company’s common stock will temporarily remain listed for quotation on OTC Markets under the current symbol “CTCO” until a new symbol is assigned by Financial Industry Regulatory Authority, Inc. (FINRA). The Company will publicly announce the new trading symbol when assigned by FINRA and the effective date of the symbol change.

Peak Pharmaceuticals President and CEO Dr. Soren Mogelsvang states, “The name change was made to make our name more consistent with our business operations and plans relating to development, manufacturing and marketing of hemp-based, pharmaceutical-grade, nutraceutical and supplement products for the human and animal health markets.”

Additional details of the Company’s business, finances, appointments and agreements can be found as part of the Company’s continuous public disclosure as a reporting issuer with the Securities and Exchange Commission (“SEC”) available at For more information please visit

About Peak Pharmaceuticals, Inc. (OTCQB: CTCO)
Peak Pharmaceuticals, Inc. specializes in the development, manufacturing, sales and marketing of pharmaceutical-grade, hemp-based nutraceutical and supplement products for the human and animal health markets. The company aims to become a global leader in the research, development, sales and marketing of medicinal hemp and cannabinoid products. For more information visit and follow us on Facebook, Twitter and LinkedIn.

Safe Harbor Statement
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the availability of additional funding; the early-stage nature of the industry sector; regulatory changes affecting the sale, transport or consumption of Cannabidiol or hemp based products by humans or animals; commercial impacts to the Company’s business, related agreements, product development, marketing and distribution plans and strategies. These and other factors are identified and described in more detail in the Company’s filings with the SEC, including, the Company’s current reports on Form 8-K. The Company does not undertake to update these forward-looking statements. FDA Disclosure: The statements in this news release have not been evaluated by the Food and Drug Administration (FDA). The products and statements mentioned in this release are not intended for humans, or to diagnose, treat, cure, or prevent any disease.

Soren Mogelsvang
President & CEO
Peak Pharmaceuticals, Inc.

For additional information, please contact:
Peak Pharmaceuticals, Inc.
Investor Relations
T: +1 (800) 713-9091

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 |
1 comment
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$THCZ Snowflake Design Revealed for National Accounts

New Rocky Mountain High Snowflake Design Revealed for National Accounts    Totally…

Village Farms International, Inc. (VFF) Cannabis JV Pure Sunfarms Receives Health Canada Approval for State-of-the-Art Processing Center

Village Farms International’s Cannabis JV Pure Sunfarms Receives Health Canada Approval for…

Choom Holdings Inc. (CHOOF) Announces Private Placement of Convertible Debentures

Choom Announces Private Placement of Convertible Debentures Choom Holdings Inc. (the “Company”…

American Premium Water Corporation (HIPH) Could Potentially Surge More Than 600% Based on Recent Price Targets

American Premium Water Corp (OTC: HIPH) Could Potentially Surge More Than 600%…